BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1717573)

  • 1. Identification of an immunodominant B cell epitope on the hepatitis C virus nonstructural region defined by human monoclonal antibodies.
    Cerino A; Mondelli MU
    J Immunol; 1991 Oct; 147(8):2692-6. PubMed ID: 1717573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A human monoclonal antibody specific for the N terminus of the hepatitis C virus nucleocapsid protein.
    Cerino A; Boender P; La Monica N; Rosa C; Habets W; Mondelli MU
    J Immunol; 1993 Dec; 151(12):7005-15. PubMed ID: 7505020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-cell epitopes on the hepatitis C virus nucleocapsid protein determined by human monospecific antibodies.
    Akatsuka T; Donets M; Scaglione L; Ching WM; Shih JW; Di Bisceglie AM; Feinstone SM
    Hepatology; 1993 Sep; 18(3):503-10. PubMed ID: 7689529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
    Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
    Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins.
    Gerlach JT; Ulsenheimer A; Grüner NH; Jung MC; Schraut W; Schirren CA; Heeg M; Scholz S; Witter K; Zahn R; Vogler A; Zachoval R; Pape GR; Diepolder HM
    J Virol; 2005 Oct; 79(19):12425-33. PubMed ID: 16160170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of mimotopes mimicking an immunodominant conformational epitope on the hepatitis C virus NS3 helicase.
    Jolivet-Reynaud C; Adida A; Michel S; Deléage G; Paranhos-Baccala G; Gonin V; Battail-Poirot N; Lacoux X; Rolland D
    J Med Virol; 2004 Mar; 72(3):385-95. PubMed ID: 14748062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of the phage display technology for the identification of a hepatitis C virus NS4A epitope recognized early in the course of the disease.
    Ferrieu-Weisbuch C; Bettsworth F; Becquart L; Paranhos-Baccala G; Michel S; Arnaud M; Jolivet-Reynaud C
    J Virol Methods; 2006 Feb; 131(2):175-83. PubMed ID: 16183141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
    Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C.
    Erickson AL; Houghton M; Choo QL; Weiner AJ; Ralston R; Muchmore E; Walker CM
    J Immunol; 1993 Oct; 151(8):4189-99. PubMed ID: 7691940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of a panel of monoclonal antibodies raised against recombinant HCV core protein.
    Ferns RB; Tuke PW; Sweenie CH
    J Med Virol; 1996 Nov; 50(3):221-9. PubMed ID: 8923286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a linear epitope in the nonstructural region 4 of hepatitis C virus with reactivity to seroconversion antibodies.
    Wienhues U; Ihlenfeldt HG; Seidel C; Schmitt U; Kraas W; Jung G
    Virology; 1998 Jun; 245(2):281-8. PubMed ID: 9636367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production and characterization of a human monoclonal antibody to the hepatitis C virus NS4 region.
    Mondelli MU; Cerino A; Bellotti V; de Lalla C; Rosa C; Bonelli F; Habets W
    Year Immunol; 1993; 7():220-6. PubMed ID: 8396822
    [No Abstract]   [Full Text] [Related]  

  • 13. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia.
    Lechmann M; Ihlenfeldt HG; Braunschweiger I; Giers G; Jung G; Matz B; Kaiser R; Sauerbruch T; Spengler U
    Hepatology; 1996 Oct; 24(4):790-5. PubMed ID: 8855177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection.
    Bain C; Parroche P; Lavergne JP; Duverger B; Vieux C; Dubois V; Komurian-Pradel F; Trépo C; Gebuhrer L; Paranhos-Baccala G; Penin F; Inchauspé G
    J Virol; 2004 Oct; 78(19):10460-9. PubMed ID: 15367612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients.
    Lok AS; Chien D; Choo QL; Chan TM; Chiu EK; Cheng IK; Houghton M; Kuo G
    Hepatology; 1993 Sep; 18(3):497-502. PubMed ID: 7689528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections.
    Ferrari C; Valli A; Galati L; Penna A; Scaccaglia P; Giuberti T; Schianchi C; Missale G; Marin MG; Fiaccadori F
    Hepatology; 1994 Feb; 19(2):286-95. PubMed ID: 8294086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
    J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cloning of the immunodominant regions of hepatitis C virus type III and IV by immunoscreening.
    Sato A; Kazami J; Arima T; Nakamura H; Kunitomo T
    Acta Virol; 1993; 37(2-3):132-42. PubMed ID: 7692715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with C100-3 protein.
    Nagayama R; Tsuda F; Okamoto H; Wang Y; Mitsui T; Tanaka T; Miyakawa Y; Mayumi M
    J Clin Invest; 1993 Sep; 92(3):1529-33. PubMed ID: 7690782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of three novel monoclonal antibodies against hepatitis C virus core protein.
    Moradpour D; Wakita T; Tokushige K; Carlson RI; Krawczynski K; Wands JR
    J Med Virol; 1996 Mar; 48(3):234-41. PubMed ID: 8801283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.